Eric Wibaux serves as the France General Manager at Insulet Corporation since February 2018, where responsibilities include general management in the French market for an innovative medical device company focused on improving the lives of individuals with diabetes. Wibaux successfully established the French affiliate from inception, growing it into a 100 M€ business. Prior to Insulet, Wibaux held multiple leadership roles at Eli Lilly and Company from February 2004 to January 2018, including National Sales Director positions in Diabetes, Pediatric Endocrinology, Russia, and CNS in France, as well as marketing manager for Cymbalta in France and strategic planner for Zyprexa. Wibaux's career commenced at Pechiney as a Production Manager in China from September 1997 to September 1999. Educational qualifications include an MBA from INSEAD, a Diplôme d'ingénieur from CentraleSupélec, and a Maîtrise in theoretical and mathematical physics from Université Paris-Saclay.
This person is not in any teams
This person is not in any offices